Chimerix Inc (CMRX) Q3 2024: Everything You Need to Know Ahead of Earnings [Yahoo! Finance]
Chimerix, Inc. (CMRX)
Last chimerix, inc. earnings: 2/25 07:00 am
Check Earnings Report
US:NASDAQ Investor Relations:
ir.chimerix.com/investor-relations
Company Research
Source: Yahoo! Finance
The full year 2024's revenue is expected to be $5.94 million and the earnings are expected to be -$0.92 per share. More detailed estimate data can be found on the Forecast page Warning! GuruFocus has detected 7 Warning Signs with CMRX. Revenue estimates for Chimerix Inc ( NASDAQ:CMRX ) have declined from $7.73 million to $5.94 million for the full year 2024 and from $3 million to $2.03 million for 2025 over the past 90 days. Earnings estimates have declined from -$0.88 per share to -$0.92 per share for the full year 2024 and increased from -$1.00 per share to -$0.98 per share for 2025 over the same period. In the previous quarter of 2024-06-30, Chimerix Inc's ( NASDAQ:CMRX ) actual revenue was $0.13 million, which beat analysts' revenue expectations of $0.063 million by 104.76%. Chimerix Inc's ( NASDAQ:CMRX ) actual earnings were -$0.23 per share, which met analysts' earnings expectations. After releasing the results, Chimerix Inc ( NASDAQ:CMRX ) was down by -6.16% in one day.
Show less
Read more
Impact Snapshot
Event Time:
CMRX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
CMRX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
CMRX alerts
High impacting Chimerix, Inc. news events
Weekly update
A roundup of the hottest topics
CMRX
News
- Chimerix, Inc. (NASDAQ: CMRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $11.00 price target on the stock.MarketBeat
- Chimerix, Inc. (NASDAQ: CMRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $6.00 price target on the stock.MarketBeat
- Why Is Cancer-Focused Chimerix Stock Trading Higher On Tuesday? [Yahoo! Finance]Yahoo! Finance
- Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-End [Yahoo! Finance]Yahoo! Finance
- Chimerix to Submit Dordaviprone for Accelerated Approval to U.S. FDA for Patients with Recurrent H3 K27M-Mutant Diffuse Glioma Before Year-EndGlobeNewswire
CMRX
Earnings
- 11/7/24 - Miss
CMRX
Sec Filings
- 12/10/24 - Form 8-K
- 11/14/24 - Form 8-K
- 11/7/24 - Form 10-Q
- CMRX's page on the SEC website